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ABSTRACT
Although many proteins are known to function in
microRNA (miRNA)-based translational repression,
we lack a comprehensive understanding of temporal
relationships between the mRNA, miRNA and their
constituent proteins. To understand the dynamics
of miRNA and protein interactions, we created a
synthetic inducible miRNA system in mammalian
cells. By visualizing single mRNAs and observing
their co-localization with proteins over time, we
produced a temporal association map of miRNA-
associated factors. Argonaute2, Dcp1a, hedls and
Rck co-localize with miRNA-regulated mRNA after
24h of miRNA induction, and RNAi knockdown of
any one of these proteins affected the co-localiza-
tion of any of the other proteins with miRNA-
regulated mRNA, demonstrating that these proteins
could interact with each other in a complex. We
identified Argonaute2 and hedls as proteins that
co-localize and interact with miRNA-regulated
mRNA, indicating that processing body components
are involved in long-term storage of miRNA-
regulated mRNA.
INTRODUCTION
microRNA (miRNA)-directed translational repression, a
process in which miRNA serves as a guide for the
RNA-induced silencing complex (RISC) to bind comple-
mentary target mRNA and arrest translation, regulates
many genes including those involved in development (1)
and heterochromatin formation (2). Defects in miRNA
regulation result in a wide range of disorders including
leukemia, lymphoma and fragile X syndrome (3–5).
Despite much research over the last decade, questions
remain about the fate of mRNA following miRNA-
directed translational repression.
Processing bodies (P bodies) are known as sites of
mRNA degradation for nonsense or AU-rich
element-mediated decay (6,7). Similarly, it was thought
that Argonaute proteins in the RNA-induced silencing
complex (RISC) direct mRNA to P bodies during trans-
lational repression for future degradation (8). However,
recent evidence suggests that Argonaute-directed repres-
sion and mRNA degradation occur in the absence of P
bodies, indicating that miRNA-regulated mRNA localiza-
tion to P bodies is not necessary for mRNA degradation
(9). Additionally, not all translationally repressed mRNA
is degraded; up to 50% of repressed mRNA can be left
intact in P bodies (10) and re-enter translation (11,12).
These observations suggest that P bodies can store re-
pressed mRNA for rapid translational reactivation.
Stress granules, which form under adverse conditions,
are also implicated in general translational repression.
Stress granules not only share some of the same proteins
as P bodies, but also posses unique translation initiation
proteins such eIF3, eIF4G and PABP (13), and contain
abortive translation initiation complexes (14). Evidence
indicates that miRNA-directed translational repression
could occur by inhibiting translation initiation (15), thus
RISC could interact with translation initiation compo-
nents in stress granules. Stress granules also lack mRNA
decapping enzymes (6,13); they therefore do not degrade
mRNA and could store mRNA for future translation.
Many P body and stress granules components have
already been identiﬁed, but we do not know how they con-
tribute to degradation or storage of miRNA-regulated
mRNA.
To understand how RISC, P body and stress granule
components interact temporally with miRNA-regulated
mRNA during and after translational repression, we
used single molecule ﬂuorescent in situ hybridization
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ing (IF) of endogenous proteins. We found that
Argonaute2, Dcp1a, hedls and Rck co-localize with
miRNA-regulated mRNA after 24h of miRNA induction,
suggesting that these proteins could be involved in mRNA
storage. We found that RNAi knockdown of any one of
these proteins affected the co-localization of other proteins
with miRNA-regulated mRNA, indicating that these
proteins could interact with each other in a complex. We
further demonstrated that Arognaute2 and hedls interact
with the miRNA-regulated mRNA, indicating that P body
components are involved in miRNA-regulated mRNA
storage after miRNA-based mRNA degradation.
MATERIALS AND METHODS
Transgene construction
JDS33 was constructed using Biobrick construction
methods (16) and previously characterized Biobrick
parts. It consists of a Tet-On Doxycycline promoter
fused to luc-1601 miRNA (17), two copies of YFP and a
nuclear localization sequence inserted into a modiﬁed
pcDNA3.1+/Puro vector (Invitrogen) with a deleted
CMV promoter. The transcribed RNA would therefore
be an intronic miRNA spliced out during mRNA matur-
ation and two linked copies of YFP transcript attached to
RNA encoding a nuclear localization signal. JDS48 and
other luciferase reporter target plasmids were constructed
by inserting four to ﬁve copies of target sequences to luc-
1601 miRNA that are either of mismatched (CXCR4),
imperfect (miRNA, JDS48) or perfect (siRNA) comple-
mentarity into the MCS of pmirGLO vector (Promega),
which expresses both ﬁreﬂy and renilla luciferase.
Cell culture and cell line construction
All cell lines originated from U2OS cells and were grown
in McCoy’s 5A media (Invitrogen) supplemented with
10% tetracycline-screened FBS (HyClone) and 1% peni-
cillin/streptomycin (Invitrogen). All transfections were
conducted with Lipofectamine 2000 and OptiMEM
media using the standard manufacturer’s protocol
(Invitrogen). JDS33 plasmid was transfected into U2OS
Tet-On cell line (ClonTech), randomly integrated and
single clones isolated using puromycin (Sigma) selection
for low basal YFP levels and high YFP levels upon induc-
tion. JDS48 was then co-transfected with pCMV/Zeo
(Invitrogen) into the integrated JDS33-expressing cell
line, randomly integrated and single clones isolated using
zeocin (Invitrogen) selection for high-luciferase activity to
produce JDS33/48.
Single molecule FISH—immunoﬂuorescent co-staining
smFISH-IF co-staining protocol was modiﬁed from a
protocol used by Raj et al. (18) 65 probes against the
luc2 gene in the pmirGLO vector were designed using
the program available online at http://www
.singlemoleculeﬁsh.com. Probes were ordered with
30-amino modiﬁcations (BioSearch Technologies),
coupled to Cy-5 ﬂuorophore (GE Healthcare) and
HPLC puriﬁed. JDS33/48 cells were plated for 24h in
multi-well 1.5 thickness glass bottom culture plates
(MatTek). To JDS33/48 cells, 1mg/ml doxycycline was
added for the indicated time periods. mRNA transcription
was inhibited by adding 50mM dichlorobenzimidizole
riboside (DRB) 5h prior to ﬁxing cells. At the indicated
times, JDS33/48 cells were ﬁxed with formaldehyde,
washed with PBS and stored overnight in 70% ethanol.
The next day they were washed with buffer (2  SSC, 10%
foramide, RNase-free water) and then incubated over-
night at 28 C in hybridization buffer (10% dextran sulfate,
2mM vanadyl-ribonucleoside complex, 0.02% RNAse-
free BSA, 1mg/ml Escherichia coli tRNA, 2  SSC, 10%
foramide, RNase-free water) with Cy-5 labeled probes and
primary antibody against the protein of interest. We did
not perform a blocking step prior to primary antibody
incubation to prevent introduction of RNases. All incu-
bations were conducted in the dark. Primary antibody
sources and working concentrations are detailed on
Supplementary Table S1. The next day cells were aspi-
rated, washed, and incubated for one hour at room tem-
perature in hybridization buffer with species-speciﬁc Cy-3
secondary antibodies (Jackson ImmunoResearch) at 1/200
dilution. They were then washed, incubated for 30min at
room temperature in wash buffer containing 5ng/ml
DAPI, and after a ﬁnal wash mounted in freshly
prepared oxygen depleted mounting media.
Data acquisition and analysis
Live cell time-lapse experiments were conducted in a 5%
CO2 incubation chamber set at 37 C on a Nikon TE2000E
motorized inverted microscope with Perfect Focus System,
Prior Proscan II motorized stage and shutters and Prior
LumenPro light source. Images were acquired each hour
with a  20 objective with a 500-ms exposure time from
a Hamamatsu ORCA-ER cooled CCD camera with
Metamorph image acquisition software (Molecular
Devices). smFISH-IF ﬁxed cell images were taken on a
Nikon TE2000E inverted ﬂuorescence microscope with
Nikon motorized stage, excitation and emission wheels
and X-Cite 120Q Fluorescence Illumination system
(Lumen Dynamics). Images were acquired with a  100
objective with 100, 200 and 1500ms exposure times for
DAPI, Cy-3 and Cy-5, respectively, from a Hamamatsu
ORCA-ER cooled CCD camera with Metamorph image
acquisition software (Molecular Devices). All images were
analyzed using ImageJ software. For the live cell
time-lapse images, base threshold was set at 3  the
average intensity of the entire image at t=0h.
smFISH-IF images were analyzed by local background
subtraction and thresholding, with data from the nucleus
excluded by DAPI staining. Co-localization was scored
using the AND function on ImageJ. Heat map numbers
were generated by calculating the ratio of co-localized foci
normalized to the total number of protein foci multiplied
by 100. This value is essentially the percentage of
co-localized foci normalized to the total amount of
protein. Number of cytoplasmic mRNA transcripts per
cell was approximated by totaling the number of mRNA
foci outside of nuclei then dividing by the total number of
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nucleii. Luciferase activity assays were conducted using
the Dual-Glo Luciferase Assay System (Promega).
mRNA transcription was inhibited by adding 50mM
DRB 5h prior to taking data points. Fireﬂy luciferase
activity levels were normalized to renilla luciferase
activity levels to control for differences in transcriptional
and translational efﬁciency.
RNA immunoprecipitation and qPCR
Magnetic Dynabeads Protein G and A (Invitrogen) were
washed four times in 500ml RNA immunoprecipitation
(RIP) buffer (50mM Tris, pH 7.0, 0.5% Triton X-100,
150mM NaCl, 1mM EDTA, 10% glycerol) using a
magnetic rack. Antibodies were precoupled to beads in a
solution comprised of 445ml RIP buffer, 10ml antibody,
50 ul 10mg/ml BSA and 5ml yeast tRNA. This solution
was rocked for 2h at 4 C and afterwards washed three
times in 1ml RIP buffer. Cells were washed with
DEPC-PBS, scraped off, spun down, resuspended in
1ml of freshly made cell lysis buffer [RIP buffer, 1:40
RNaseOUT (Invitrogen), 1:100 PMSF (17.5mg/ml in
methanol), 1:2200 RNasin (Promega)] and rocked for
10min at 4 C. Cell lysate was then spun down to
remove debris and the supernatant was added to the
magnetic beads and rocked for 4h at 4 C. Afterwards
the beads were then washed 6  in 1ml RIP buffer with
freshly added 1:200 PMSF (17.5mg/ml) and 1:100 1M
DTT. The beads were then resuspended in 200ml elution
buffer [RNA storage solution (Ambion), 1% SDS, 1mM
EDTA, 1:100 1M DTT] per sample. They were eluted for
10min at 65 C, and quickly vortexed every 3–4min. RNA
was then acid/phenol/chloroform extracted from the
elution, separated with Heavy Phase Lock Gel tubes
(Fisher) and ethanol precipitated overnight. The RNA
was reverse transcribed with SuperscriptIII (Invitrogen)
according to the standard protocol and qPCR was per-
formed using SYBR Green (Applied Biosystems). Primers
for the qPCR of ﬁreﬂy luciferase were 50-gccatgaagcgc
tacgccctgg-30 and 50-tcttgctcacgaatacgacggtgg-30. Primers
for renilla luciferase were 50-tcagtggtgggctcgctgca-30 and
50-ctttggaaggttcagcagctcg-3 0
Western blot
First NuPage LDS sample buffer (Invitrogen) was added
to each sample, and they were then heated at 100 C for
10min and air cooled. Samples were run on a NuPage 4–
12% Bis–Tris gel (Invitrogen) with 1  NuPage MES
buffer (Invitrogen) with Precision Plus Protein Dual
Color Standard (Biorad) at 120V for 90min. Proteins
were transferred to PVDF membranes (Millipore) in
NuPage transfer buffer (Invitrogen) using a semidry
transfer apparatus at 150 mA for 1h. Membranes were
blocked with 5% non-fat dry milk in PBS+0.1% Tween
(blocking buffer) for 1h, then exposed to the primary
antibody (Argonaute2—1:200, Dcp2—1:500, Dcp1a—
1:2000, hedls—1:1000, Rck—1:3000) overnight at 4 C.
Membranes were washed with three times with
PBS+0.1% Tween and exposed to 1:5000 dilution
species-speciﬁc HRP antibody in blocking buffer for 1h.
They were then washed three times with PBS+0.1%
Tween and 1ml each of Western Lightning Plus-ECL
Luminol and Oxidixing Reagents were added for 1min.
Membranes were exposed to Kodak Scientiﬁc Imaging
Film and developed in a darkroom.
mRNA lifetime calculation
JDS33/48 cells were plated for 24h in multi-well 1.5 thick-
ness glass bottom culture plates (MatTek). At 0, 1, 2, 3 or
4h prior to cell ﬁxation, 50mM dichlorobenzimidizole
riboside (DRB) was added and smFISH staining was con-
ducted (18). Approximately 50 cells were imaged for each
time point, and number of cytoplasmic mRNA per cell
was approximated by totaling the number of mRNA
foci outside of nuclei in pictures then dividing by the
total number of complete nuclei in each picture. The
median of each hour was taken and used to ﬁt a linear
mRNA decay equation. The average mRNA lifetime was
then extrapolated from that equation.
siRNA transfection
Standard siGENOME SMARTpool siRNAs for
Argonaute2 (eIF2C2), Dcp1a, hedls (EDC4) and Rck
(DDX6) were ordered from Dharmacon. siRNA transfec-
tion was conducted using HiPerFect Transfection Reagent
and the standard manufacturer’s protocol (Qiagen). All
siRNAs used in RNAi studies were transfected 54h
before ﬁxation. Induction with doxycycline occurred 24,
12, 6 and 0h prior to ﬁxation, respectively.
RESULTS AND DISCUSSION
Designing miRNA-based silencing of a target reporter
gene
In order to conduct a temporal study of RISC, P body and
stress granule component co-localization with miRNA-
regulated mRNA, we constructed a synthetic miRNA ex-
pression system capable of inducible silencing of a target
reporter mRNA. In human U2OS cells, we stably ex-
pressed an intronic miRNA (luc-1601 miRNA) (17)
coupled to two copies of the gene encoding the yellow
ﬂuorescent protein (YFP) with a nuclear localization
signal (NLS) under a doxycycline-inducible promoter.
Nuclear-localized YFP expression serves as an indirect in-
dicator of miRNA expression. We then stably expressed a
ﬁreﬂy luciferase gene with ﬁve copies of a target sequence
in the 30 untranslated region (UTR) that is imperfectly
complementary to the miRNA under a constitutive human
phosphoglycerate kinase (HPGK) promoter (Figure 1A).
We call this cell line JDS33/48. In the absence of doxycyc-
line inducer, YFP and miRNA are not expressed and
JDS33/48 cells generate a strong ﬁreﬂy luciferase reporter
signal. When doxycycline is added, miRNA and YFP pro-
duction is induced resulting in a substantial increase in
nuclear YFP signal as well as a 50–60% decrease in
ﬁreﬂy luciferase activity (Figure 1B and C) and a 10-fold
decrease in ﬁreﬂy luciferase mRNA levels after 48h
(Supplementary Figure S1A). Dichlorobenzimidizole
riboside (DRB), an RNA Polymerase II inhibitor, was
7742 Nucleic Acids Research, 2011,Vol.39, No. 17added to cells during miRNA induction for 5h prior to
assaying to inhibit transcription of new mRNAs. Over
80% of JDS33/48 cells have signiﬁcant YFP expression
after 12h while luciferase activity does not substantially
decrease until 24–36h after doxycycline induction. This
delay reﬂects the lag time between miRNA transcription
and maturation, miRNA-based silencing of the target
mRNA and degradation of the luciferase protein.
To conﬁrm that the miRNA speciﬁcally targets the
luciferase reporter and that the decrease in luciferase
activity is due to miRNA-speciﬁc targeting, we conducted
transient co-transfections of the doxycycline-inducible
luc-1601 miRNA-YFP construct with luciferase reporters
containing different targets in their 30-UTR. After
co-transfection we induced miRNA expression and mea-
sured luciferase activity levels after 48h (Supplementary
Figure S1B). No silencing was observed for ﬁreﬂy
luciferase reporters lacking target sequences or containing
mismatched CXCR4 target sequences in the 30-UTR,
demonstrating that luciferase reporter activity is not damp-
ened by nuclear YFP expression and that non-speciﬁc
target sequences are not recognized by the luc-1601
miRNA. Target sequences with imperfect (miRNA) or
perfect (siRNA) complementarity display signiﬁcant
silencing after 48h, indicating that the luc-1601 miRNA
does speciﬁcally target mRNAs with complementary
target sequences. Therefore, we have successfully
designed and validated an inducible miRNA expression
system.
Co-localization of proteins with miRNA-regulated mRNA
To determine the temporal association of RISC, P body
and stress granule components with miRNA-regulated
mRNA, we used smFISH (18) to localize ﬁreﬂy luciferase
mRNA combined with IF of various P body and stress
granule components to examine JDS33/48 cells ﬁxed at
various time points after doxycycline induction of
miRNA. Choosing timepoints based on YFP expression
and luciferase reporter silencing assays (Figure 1), we ﬁxed
cells at 0, 6, 12 and 24h after doxycycline induction in
order to capture the widest range of temporal association.
DRB was added to cells 5h prior to ﬁxation, following the
doxycyline-mediated miRNA induction to terminate
reporter mRNA transcription. We used smFISH to
measure mRNA numbers 0–4h after transcription block
with DRB to produce an mRNA decay curve and
measured average mRNA lifetime to be 14.07±1.76h
(Supplementary Figure S1C). Therefore each time point
represents mRNA transcripts that are at least 5h old at
the sampling time.
As a proof of concept experiment, we conducted
smFISH-IF co-staining of mRNA with antibodies against
Argonaute2 and hedls. smFISH-IF co-staining followed
by wide-ﬁeld microscopy imaging with background
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Figure 1. Doxycycline induction of miRNA correlates with increased nuclear YFP and reduced luciferase reporter levels. (A) Schematic of constructs
stably integrated in U2OS cells. Doxycycline induction produces intronic miRNA targeting the 30-UTR of a luciferase reporter mRNA. Nuclear YFP
is also expressed as an indirect readout of miRNA production. (B) The majority of cells produce signiﬁcant levels of nuclear YFP by 12h of
doxycycline induction. Threshold is 3  mean background levels of YFP expression before doxycyline induction (0h). N   300 cells, three replicates
per data point. (C) Doxycycline induction results in reduced luciferase activity. N=3 replicates per data point. Error bars=standard deviation.
Nucleic Acids Research, 2011,Vol.39, No. 17 7743subtraction produced images showing punctate spots of
mRNA probe and protein antibody. We found no
co-localization of target mRNA with hedls prior to
miRNA induction (Figure 2A), while Argonaute2 initially
displayed signiﬁcant levels of mRNA co-localization
(Figure 2C). Upon induction of miRNA, co-localization
of Argonaute2 with mRNA remained high while hedls
co-localization steadily increased such that 24h after
miRNA induction there were high levels of mRNA
co-localization for both proteins (Figure 2B and D).
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Figure 2. Single molecule FISH combined with immunoﬂuorescence shows mRNA co-localization with RISC and P body proteins when miRNA is
expressed. (A–D) smFISH-IF co-staining of protein antibody (green, Cy-3) and luciferase reporter mRNA (red, Cy-5) at various times after doxy-
cycline induction of mRNA. Blue=DAPI. White arrows point to examples of co-localization. Yellow arrows point to co-localization shown at 5 
size in the inset of the same picture. (A) Hedls, 0h. (B) Hedls, 24h. (C) Argonaute, 0h. (D) Argonaute2, 24h. (E) Luciferase reporter mRNA levels
are reduced when miRNA is expressed. Average number of cytoplasmic mRNA foci per cell 0, 6, 12 and 24h after doxycycline induction of miRNA.
N=52 cells for 0h, 48 cells for 6h, 51 cells for 12h and 50 cells for 24h. Error bars=95% conﬁdence interval for means.
7744 Nucleic Acids Research, 2011,Vol.39, No. 17In addition to identifying intracellular mRNA localiza-
tion, smFISH also allows us to approximate cytoplasmic
mRNA levels per cell as each spot of minimal intensity is
equivalent to one mRNA (18). An average of cytoplasmic
mRNA transcripts per cell shows a substantial decrease in
mRNA levels after miRNA induction, with mRNA levels
remaining low and relatively unchanged after 24h of
miRNA induction (Figure 2E). This visual demonstration
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Figure 3. P body and RISC proteins temporally co-localize with miRNA-regulated mRNA. (A) Heat map of protein temporal association with
miRNA-regulated mRNA. Data points are taken 0, 6, 12 and 24h after doxycyline induction of miRNA. Number of co-localized foci is divided by
number of total protein foci to normalize for variable protein levels and get percentage of protein interacting with the target mRNA. Group
A=proteins with high scores when miRNA is expressed. Group B=proteins with high scores in the ﬁrst 6–12h, presumably during active RNAi
degradation of mRNA. Group C=proteins with low scores overall. Zero-hour control is the association score in a cell line with only the luciferase
reporter to control for miRNA leakiness. Each data point is an aggregate of ﬁve images with 20 cells total. A statistical analysis was conducted
comparing differences between population proportions of the 0-h time point to each other time point for each protein, except for Argonaute2 and
Dcp1a which were compared to hedls at 0h. Bold/italicized numbers indicate results signiﬁcantly >0-h time point and underlined numbers indicate
results signiﬁcantly <0-h time point (P<0.05). (B) The average maximum image intensity for each antibody either mock transfected (mock RNAi) or
transfected with siRNA targeting the protein (RNAi). Data for each protein was normalized to mock RNAi. Error bars=standard deviation.
N=15. (C–G) Images of JDS33/48 cells either mock transfected (left) or transfected with siRNA (right) targeting (C) Argonaute2, (D) Dcp1a, (E)
hedls, (F) Rck or (G) Dcp2. Cells were ﬁxed 48h after transfection and smFISH-IF co-staining of protein, the appropriate antibody (green, Cy-3)
and luciferase reporter mRNA (red, Cy-5) was conducted. Blue=DAPI.
Nucleic Acids Research, 2011,Vol.39, No. 17 7745of mRNA molecules decreasing when miRNA targeting
the mRNA is expressed is in agreement with ribosome
proﬁling data (19), which shows a large decrease in en-
dogenous target mRNA levels upon miRNA expression.
Additionally, our results indicate that mRNA degradation
happens within the ﬁrst 24h of miRNA expression in
mammalian cells, with a lag time for a correlated
decrease in protein activity based on the protein half-life.
We conducted a targeted temporal association screen of
RISC, P body and stress granule components in order to
determine which proteins co-localize with mRNA targeted
by miRNA at speciﬁc times. A heat map summarizing the
results of the experiments shows that there are patterns
of temporal protein co-localization with miRNA-
regulated mRNA that can be organized into three
groups (Figure 3A). We generated the numbers on the
heat map by calculating the ratio of co-localized foci
normalized to the total number of protein foci and multi-
plying by 100. This value is the percentage of co-localized
foci normalized to the total amount of protein.
Group A proteins, comprised of Argonaute2, Dcp1a,
hedls and Rck, co-localize with mRNA throughout
miRNA induction. The consistent co-localization indi-
cates that they could be involved in miRNA-based
mRNA storage as they are still co-localized with mRNA
after 24h of miRNA induction. Argonaute2 is a
well-known RISC component that is also associated
with P bodies (20). Dcp1a, hedls and Rck are P body
components involved in mRNA decapping and degrad-
ation. Argonaute2 and Dcp1a both have high levels of
protein interaction with the target mRNA prior to
miRNA induction, suggesting that there may be leakiness
in the inducible promoter. To control for miRNA leaki-
ness, we conducted smFISH-IF experiments for group A
proteins in a cell line containing only the luciferase
reporter (Figure 3A, 0-h control). Statistical analysis
comparing the differences between population propor-
tions for each of the group A proteins revealed no statis-
tical difference (P>0.05) between the 0-h controls and the
0-h timepoints, demonstrating that some Argonaute2 and
Dcp1a interaction with the reporter mRNA occurs
without the presence of miRNA.
Group B proteins, such as Rent1, Dicer1, FMR1,
GW182 and TRBP, co-localize with the target mRNA
6–12h after miRNA expression, indicating that they are
associated with miRNA-targeted mRNA degradation as
the rapid decrease in reporter mRNA levels occurs at these
times (Figure 2E). That the majority of proteins in Group
B are RISC components, such as FXR1, FXR2, FMR1,
GW182 and TRBP, further supports the idea that
miRNA-targeted mRNA degradation occurs at this time.
Group C proteins do not signiﬁcantly co-localize with
the target mRNA at any time in our screen. However,
proteins in Group C cannot be deﬁned as lacking any
association with miRNA-regulated mRNA and may
simply not associate for enough time to be observed in
our assay. For example, it is interesting to note that pre-
dominantly stress granule proteins were not found in
Group A proteins. Evidence from other groups shows
that individual mRNAs interact for only a few minutes
with stress granules during stress-induced translational
arrest (21), implying that individual mRNA transcripts
do not associate with stress granules long enough to be
detectable in our screen.
Hedls and Rck have both been shown to interact with
Dcp2 and Dcp1a, with hedls promoting the complex for-
mation between Dcp2 and Dcp1a as well as enhancing
Dcp2 decapping activity (22). However, we do not detect
Dcp2 co-localizing with targeted mRNA at any time in
our experiments. To validate the protein–mRNA
co-localization seen in our screen (Figure 3A), we trans-
fected pooled siRNAs corresponding to each of the Group
A proteins and Dcp2 into the JDS33/48 cell lines. If the
protein staining is speciﬁc then RNAi knockdown of each
individual protein would lead to a reduction in antibody
staining. Indeed, we found antibody staining intensity for
each protein dropped when compared to a mock RNAi
control (Figure 3B–G), validating both the efﬁcacy of
RNAi against each protein and the co-localization of
Group A proteins with miRNA-regulated mRNA seen
in the screen (Figure 3A). This indicates that Dcp1a,
hedls and Rck are co-localizing with mRNA independent
of Dcp2 activity, implying a non-decapping function for
these proteins without Dcp2 present. The modularity of P
body components has been noted before. In Drosophila S2
cells EDC3, a P body component involved in mRNA
decapping (22), and TraI, a P body component involved
in translational control of maternal mRNA (23), do not
interact with each other and are mutually exclusive
because they bind to the same binding sites on Dcp1
and Me31B (24). However, EDC3 interacts with both
Dcp1 and Dcp2 while TraI only interacts with Dcp1,
demonstrating that Dcp1 and Dcp2 can be in separate
protein complexes with unique functions (24). Other alter-
native explanations are that the supply of Dcp2 protein is
limited such that most of it cannot co-localize with the
Group A Group B
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to STRING 8.3 
interaction network
Experimentally
validated
High confidence 
predictions (>0.7)
TRBP Dicer1
GW182
FXR1 FXR2
FMR1
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Argonaute2
RISC
components
P body 
components
Legend
Figure 4. STRING 8.3 Interaction Network of Groups A and B
proteins.
7746 Nucleic Acids Research, 2011,Vol.39, No. 17synthetic mRNA or that any Dcp2 interaction with the
target mRNA is too brief to detect since any active
Dcp2 could lead to mRNA decapping and degradation.
Finding functionality in the temporal association of
proteins with miRNA-regulated mRNA
We speculate that proteins with the same temporal asso-
ciation could interact with each other or be part of the
same complex. To see if the protein in the groups we
characterized (Figure 3A) are known or predicted to
interact with each other, we constructed an interaction
network of Groups A and B proteins based on the
known and predicted interactions of the online STRING
8.3 Interaction Network (Figure 4) (25). Group A proteins
cluster in the center of the network, while Group B are
separated into two distinct groups. Additionally, RISC
and P body proteins cluster in their own sub-networks,
with RISC and P body components united by
Argonaute2 which is both a RISC and P body component
(20). Our association data correlates well with this inter-
action network.
The interaction network can infer which proteins will
interact with each other in an integrated protein complex.
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Figure 5. RNAi and RNA immunoprecipitation studies of Group A proteins. (A) Heat map of Group A protein interaction with miRNA-regulated
mRNA after siRNA transfection. Number of co-localized foci is divided by number of total protein foci to normalize for variable protein levels and
get percentage of protein interacting with the target mRNA. Each data point is an aggregate of ﬁve images with  20 cells total. A statistical analysis
was conducted comparing differences between population proportions of the mock RNAi control to each RNAi knockdown. Bold/italicized numbers
indicate results signiﬁcantly greater than the mock RNAi control and underlined numbers indicate results signiﬁcantly less than the mock RNAi
control (P<0.05). (B) RNAi silencing of luciferase reporter activity is inhibited when Argonaute2 and Dcp1a are targeted by siRNAs when
compared to a mock knockdown. N=3 replicates per data point. *P<0.001 compared to mock IP, Student’s t-test. (C) Quantitative RT–PCR
of targeted luciferase mRNA immunoprecipitated with antibodies to the indicted proteins. Cell extracts were obtained after cells were induced to
express miRNA for 24h. Input is RNA extracted directly from cell extracts. The mRNA levels were normalized to mock immunoprecipitation
(mock=1). The line is the mRNA level of the mock immunoprecipitation. N=2 replicates per data point. Error bars=standard deviation. (D)
Western blot of the RNA IP shows that the protein is immunoprecipitated by the antibody. The sample (S) for each RNA IP was run in between the
input (I) and a mock IP control (M). Antibodies used are noted to the left of the images.
Nucleic Acids Research, 2011,Vol.39, No. 17 7747For example, based on the interaction network we predict
that Group A proteins, which are all known components
of P bodies, should interact with each other. If this is true,
then modulating one of the Group A P body proteins
should affect the other Group A P body proteins.
Additionally, we can infer from our predicted interaction
network that Group B proteins should be in two different
complexes, one RISC-based and the other P body-based.
To validate our inferences from the interaction network
(Figure 4) for Group A proteins, we transfected pooled
siRNAs corresponding to each of the Group A proteins
into the JDS33/48 cell lines, induced miRNA expression,
ﬁxed cells at the previously determined timepoints and
conducted smFISH-IF co-staining of Group A proteins.
If Group A proteins interact with each other in a protein
complex, then RNAi knockdown of one Group A protein
would have an effect on how other Group A proteins
co-localize with the target mRNA. Additionally, if a
protein functions in miRNA-regulated mRNA degrad-
ation of the target mRNA, then knockdown of that
protein should result in less efﬁcient silencing and
increased luciferase protein levels. A heat map of Group
A protein interactions with the target mRNA after RNAi
knockdown shows that knockdown of any of the Group A
proteins modulates the co-localization of other Group A
proteins with miRNA-regulated mRNA (Figure 5A). This
data supports the idea that Argonaute2, Dcp1a, hedls and
Rck interact with each other when co-localizing with
miRNA-regulated mRNA.
Hedls knockdown reduces all of the other proteins’ as-
sociation with miRNA-regulated mRNA suggesting that
it could be required for protein interactions with the target
mRNA. However, hedls does not have any known RNA
binding domains, so it is likely that it acts as a scaffold
protein to facilitate protein interaction and other proteins
with RNA binding domains directly interact with the
target mRNA. Interestingly, while hedls knockdown de-
creases the co-localization of other proteins with target
mRNA, Rck knockdown increases co-localization of
Dcp1a and hedls with target mRNA, indicating that
hedls and Rck could be antagonistic regulators of P
body association with miRNA-regulated mRNA.
Protein co-localization with miRNA-regulated mRNA
could signify a direct role for the protein in miRNA-based
translational repression. We therefore conducted RNAi
knockdowns of each Group A protein and asked if
reducing expression levels affects miRNA silencing of
luciferase reporter activity (Figure 5B). Argonaute2 is
known to be functionally involved in miRNA-based
mRNA degradation (26), so its knockdown serves as a
control. We found that knockdown of Argonaute2 and
Dcp1a increased reporter activity, indicating that they
do have an impact on RNAi efﬁcacy. Meanwhile,
knockdown of hedls and Rck did not affect reporter
activity, demonstrating that although they co-localize
with miRNA-targeted mRNA, they are not actively
involved in degradation of miRNA-regulated mRNA.
Although hedls and Rck are not actively involved in
degradation, they could be important for storage of
undegraded miRNA-regulated mRNA. The observation
that Group A proteins co-localize with the
miRNA-regulated mRNA at the 24-h time point makes
them candidates for proteins involved in storage of
miRNA-regulated mRNA. Alternatively, some Group A
proteins may have no role in storage but are co-localized
as a consequence of interactions with proteins that do
have a storage role, much like hedls and Rck are physic-
ally associated with proteins that are involved in active
RNAi. To determine which Group A proteins interact
with miRNA-regulated mRNA after RNAi-based
mRNA degradation, we conducted an RNA immunopre-
cipitation (RIP) followed by quantitative RT–PCR of
JDS33/48 cells induced to express miRNA for 48h
(Figure 5C and D). If any of the proteins interact with
miRNA-regulated mRNA at this time, RIP would result
in enrichment for the target mRNA. We found that
Argonaute2 and hedls bound the target mRNA
compared to a mock RIP, indicating they interact with
miRNA-regulated mRNA. In contrast, Dcp1a and Rck
mRNA levels were indistinguishable from the mock
RIP, indicating that although these proteins co-localize
with miRNA-regulated mRNA, they do not interact with
the mRNA. Although Dcp1a and Rck do not interact
with the target mRNA, they do co-localize with it
(Figure 3), and Dcp1a, Rck and hedls are known to
interact with Dcp2 as part of a large complex (Figure 4)
(27). However, Dcp2 does not co-localize with the target
mRNA (Figure 3), and RIP with Dcp2 antibody resulted
in low target mRNA levels despite high Dcp2 protein
levels detected on the Western blot (Figure 5C and D).
Taken together, this signiﬁes that Dcp1a and Rck could
be co-localizing with the target mRNA due to their inter-
actions with hedls or other unidentiﬁed protein(s). The
observation that Dcp2 is not involved in this interaction
implies that while normally Dcp1a, Rck and hedls do
recruit Dcp2 for decapping, when Dcp2 is not present then
they may have a role in storage of miRNA-regulated
mRNA (Figure 6).
Figure 6. Model for protein interaction with miRNA-regulated
mRNA. After miRNA (white) is guided by RISC to its target
mRNA sequence (light gray), P body proteins are recruited through
protein–protein interactions, probably via Argonaute2. While the
majority of mRNAs are degraded within the ﬁrst 12h after miRNA
induction, mRNAs that are stored are bound in a RNA–protein
complex that includes Argonaute2, hedls, Rck and Dcp1a.
Argonaute2 and hedls interact with the mRNA while Rck and Dcp1a
interact with hedls.
7748 Nucleic Acids Research, 2011,Vol.39, No. 17In summary, we have used an interaction network in
combination with temporal co-localization to identify P
body proteins with functional relevance to RNAi and
miRNA-regulated mRNA storage. The interaction
network can be used to identify other proteins which
could be tested for interactions with miRNA-regulated
mRNA.
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